Inogen (INGN) Competitors $8.43 0.00 (0.00%) (As of 12/24/2024 01:48 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends INGN vs. AVNS, SMTI, LAKE, ZJYL, RBOT, MLSS, APT, SPAI, NTRB, and CLGNShould you be buying Inogen stock or one of its competitors? The main competitors of Inogen include Avanos Medical (AVNS), Sanara MedTech (SMTI), Lakeland Industries (LAKE), Jin Medical International (ZJYL), Vicarious Surgical (RBOT), Milestone Scientific (MLSS), Alpha Pro Tech (APT), Safe Pro Group Inc. Common Stock (SPAI), Nutriband (NTRB), and CollPlant Biotechnologies (CLGN). These companies are all part of the "surgical appliances & supplies" industry. Inogen vs. Avanos Medical Sanara MedTech Lakeland Industries Jin Medical International Vicarious Surgical Milestone Scientific Alpha Pro Tech Safe Pro Group Inc. Common Stock Nutriband CollPlant Biotechnologies Inogen (NASDAQ:INGN) and Avanos Medical (NYSE:AVNS) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their community ranking, analyst recommendations, risk, valuation, dividends, earnings, profitability, media sentiment and institutional ownership. Is INGN or AVNS more profitable? Avanos Medical has a net margin of 2.30% compared to Inogen's net margin of -15.89%. Avanos Medical's return on equity of 4.70% beat Inogen's return on equity.Company Net Margins Return on Equity Return on Assets Inogen-15.89% -27.38% -16.77% Avanos Medical 2.30%4.70%3.46% Which has more volatility and risk, INGN or AVNS? Inogen has a beta of 1.02, indicating that its share price is 2% more volatile than the S&P 500. Comparatively, Avanos Medical has a beta of 0.95, indicating that its share price is 5% less volatile than the S&P 500. Do insiders & institutionals have more ownership in INGN or AVNS? 89.9% of Inogen shares are owned by institutional investors. Comparatively, 95.2% of Avanos Medical shares are owned by institutional investors. 1.0% of Inogen shares are owned by company insiders. Comparatively, 3.9% of Avanos Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Do analysts recommend INGN or AVNS? Inogen presently has a consensus price target of $7.00, indicating a potential downside of 16.96%. Given Inogen's stronger consensus rating and higher possible upside, analysts clearly believe Inogen is more favorable than Avanos Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inogen 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33Avanos Medical 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has higher valuation and earnings, INGN or AVNS? Avanos Medical has higher revenue and earnings than Inogen. Inogen is trading at a lower price-to-earnings ratio than Avanos Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInogen$331.52M0.61-$102.45M-$2.25-3.75Avanos Medical$681.50M1.08-$61.80M$0.3447.12 Does the MarketBeat Community favor INGN or AVNS? Inogen received 302 more outperform votes than Avanos Medical when rated by MarketBeat users. Likewise, 69.41% of users gave Inogen an outperform vote while only 55.84% of users gave Avanos Medical an outperform vote. CompanyUnderperformOutperformInogenOutperform Votes38869.41% Underperform Votes17130.59% Avanos MedicalOutperform Votes8655.84% Underperform Votes6844.16% Does the media refer more to INGN or AVNS? In the previous week, Inogen had 2 more articles in the media than Avanos Medical. MarketBeat recorded 3 mentions for Inogen and 1 mentions for Avanos Medical. Inogen's average media sentiment score of 0.39 beat Avanos Medical's score of -1.04 indicating that Inogen is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inogen 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Avanos Medical 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Negative SummaryAvanos Medical beats Inogen on 10 of the 18 factors compared between the two stocks. Ad Brownstone ResearchMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines about artificial intelligence. Everyone's talking about AI right now. But see, I've been talking about it for years.I call it my AI Retirement Playbook. I recommend you check it out now. Get Inogen News Delivered to You Automatically Sign up to receive the latest news and ratings for INGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INGN vs. The Competition Export to ExcelMetricInogenSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$200.79M$9.58B$5.22B$9.25BDividend YieldN/A1.39%5.12%4.29%P/E Ratio-3.7519.5987.5917.28Price / Sales0.6132.771,166.50119.73Price / CashN/A22.3743.2337.83Price / Book0.965.764.834.93Net Income-$102.45M$182.72M$120.46M$225.34M7 Day Performance-0.82%0.31%2.85%4.14%1 Month Performance-13.80%-6.99%19.70%1.16%1 Year Performance45.85%-13.81%30.57%16.98% Inogen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INGNInogen2.6041 of 5 stars$8.43flat$7.00-17.0%+45.8%$200.79M$331.52M-3.75834AVNSAvanos Medical2.7216 of 5 stars$15.96-0.7%N/A-29.7%$733.47M$681.50M46.943,771Negative NewsSMTISanara MedTech2.2948 of 5 stars$34.60+2.7%$47.00+35.8%-8.7%$302.44M$78.06M-34.9560Analyst ForecastAnalyst RevisionNews CoverageLAKELakeland Industries4.603 of 5 stars$23.00+0.5%$27.50+19.6%+26.9%$170.34M$151.82M-255.561,750ZJYLJin Medical InternationalN/A$0.82-4.3%N/A-99.3%$127.57M$20.13M0.00245RBOTVicarious Surgical0.7601 of 5 stars$12.51+4.3%$10.25-18.1%-11.1%$73.91MN/A-1.223MLSSMilestone Scientific1.9976 of 5 stars$0.87-5.9%$1.25+43.7%+43.0%$67.77M$8.88M-12.4330APTAlpha Pro TechN/A$5.25-2.2%N/A+1.9%$57.75M$59.29M14.19120Analyst ForecastNews CoverageSPAISafe Pro Group Inc. Common StockN/A$3.61-4.0%N/AN/A$49.67M$1.56M0.0011Gap DownNTRBNutriband0.4435 of 5 stars$4.00-2.0%N/A+31.9%$44.42M$2.02M-5.6310CLGNCollPlant Biotechnologies2.1818 of 5 stars$3.43+0.6%$12.50+264.4%-32.2%$39.29M$650,000.00-2.2370Gap Up Related Companies and Tools Related Companies Avanos Medical Alternatives Sanara MedTech Alternatives Lakeland Industries Alternatives Jin Medical International Alternatives Vicarious Surgical Alternatives Milestone Scientific Alternatives Alpha Pro Tech Alternatives Safe Pro Group Inc. Common Stock Alternatives Nutriband Alternatives CollPlant Biotechnologies Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:INGN) was last updated on 12/25/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inogen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
